MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/112.5/0.1/20.12.24 | Delayed Börse Stuttgart 12:18:58 03/07/2024 pm IST | ||
| 3.28 EUR | +0.92% |
|
| Current month | -3.27% | ||
| 1 month | +25.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 3.28 | +0.92% |
| 02/24/02 | 3.25 | -7.14% |
| 01/24/01 | 3.5 | +4.17% |
| 28/24/28 | 3.36 | -1.18% |
| 27/24/27 | 3.4 | 0.00% |
Delayed Quote Börse Stuttgart
Last update July 03, 2024 at 12:18 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Morgan Stanley |
| WKN | ME1GAT |
| ISIN | DE000ME1GAT4 |
| Date issued | 03/10/2023 |
| Strike | 112.5 $ |
| Maturity | 20/12/2024 (171 Days) |
| Parity | 10 : 1 |
| Emission price | 0.71 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.6 € |
|---|---|
| Lowest since issue | 0.54 € |
| Delta | 0.87x |
| Omega | 3.570 |
| Premium | 3.17x |
| Gearing | 4.08x |
| Moneyness | 1.271 |
| Difference Strike | -30.48 $ |
| Difference Strike % | -27.09% |
| Spread | 0.09 € |
| Spread % | 2.73% |
| Theoretical value | 3.255 |
| Implied Volatility | 36.60 % |
| Total Loss Probability | 17.93 % |
| Intrinsic value | 2.833 |
| Present value | 0.4217 |
| Break even | 147.52 € |
| Theta | -0.02x |
| Vega | 0.02x |
| Rho | 0.04x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5
DKK
Average target price
952.2
DKK
Spread / Average Target
-4.16%
- Stock Market
- Warrants
- Warrant
